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CAPS (Mammalian UNC-31) Protein Localizes
to Membranes Involved
in Dense-Core Vesicle Exocytosis
CAPS (calcium-dependent activator protein for secre-
tion), a 145 kDa neural/endocrine-specific protein, was
discovered as a cytosolic factor required for Ca21-acti-
vated DCV exocytosis in permeable GH3 pituitary and
PC12 adrenal cells (Walent et al., 1992). The requirement
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for CAPS in DCV exocytosis occurs after an ATP-depen-²Department of Physiology and Cell Biology
dent priming step, probably at a very late postdockingUniversity of Kansas
stage in the exocytotic pathway immediately prior to,Lawrence, Kansas 66045
or at, the Ca21-triggered fusion step (Hay and Martin,
1992; Martin and Kowalchyk, 1997; Ann et al., 1997).
CAPS is a novel Ca21-binding protein (Ann et al., 1997)
Summary expressed in all peptide hormone±secreting endocrine
tissues (Walent et al., 1992; J. J. Wassenberg and
CAPS is a neural/endocrine-specific protein discov- T. F. J. M., unpublished data), where it is essential for
ered as a cytosolic factor required for Ca21-activated the regulated exocytosis of DCVs (Walent et al., 1992;
dense-core vesicle (DCV) exocytosis in permeable Ann et al., 1997). CAPS is also expressed at very high
neuroendocrine cells. We report that CAPS is also a levels throughout the nervous system (0.3% of cytosolic
membrane-associated, peripherally bound protein in protein, Walent et al., 1992; J. J. Wassenberg and
brain homogenates that localizes selectively to plasma T. F. J. M., unpublished data), but its role in neurosecre-
membranes and to DCVs but not to small clear syn- tion is not understood. Genetic studies indicate that
aptic vesicles (SVs). CAPS exhibits high affinity and CAPS is essential for normal nervous system activity in
saturable binding to DCVs by interaction with bilayer C. elegans, where a CAPS ortholog is encoded by the
phospholipids. Specific CAPS antibodies inhibit Ca21- unc-31 gene (Livingstone, 1991; Ann et al., 1997), which
activated norepinephrine release from lysed synap- is required for the secretion of serotonin and possibly
tosomesthat contain membrane-associated CAPS, in- other neurotransmitters (Desai et al., 1988; Avery et al.,
1993).dicating that membrane-bound CAPS is essential for
To clarify the role of CAPS in neurosecretion, we stud-neural DCV exocytosis. CAPS is a functional compo-
ied the distribution and activity of CAPS in synapto-nent of the exocytotic machinery that localizes selec-
somes. Synaptosomes are isolated presynaptic nervetively to DCVs, and it may confer distinct regulatory
terminals (Whittaker, 1969) in which regulated DCV andfeatures on neuropeptide and biogenic amine trans-
SV exocytosis have been extensively studied (Nichollsmitter secretion.
and Sihra, 1986; Verhage et al., 1991; Dekker et al.,
1991). Here, we show that a substantial fraction of brainIntroduction
CAPS is membrane associated, and that membrane-
bound CAPS in synaptosomes is primarily associated
Neural cells possess multiple regulated secretory path-
with plasma membranes and large DCVs but not SVs.
ways for the export of peptides and neurotransmitters
Membrane-bound CAPS was found to be essential for
(DeCamilli, 1991; Kelly, 1993; Bean et al., 1994). The the Ca21-triggered secretion of norepinephrine by DCV
secretion of fast-acting transmitters such as acetylcho- exocytosis. A localization of CAPS to DCVs but not SVs
line, GABA, and glutamate is mediated by the fusion of suggests that CAPS is a component specific to the DCV
small clear synaptic vesicles (SVs) with the presynaptic exocytotic pathway. As such, it could provide part of
membrane. The secretion of peptides and biogenic the basis for the distinct physiological regulation of neu-
amine transmitters occurs by the exocytosis of dense- ropeptide and biogenic amine transmitter secretion.
core vesicles (DCVs), which are homologous to the se-
cretory granules of endocrine cells (Thureson-Klein, Results
1983; Klein and Thureson-Klein, 1984). Much of the se-
cretory apparatus for the regulated exocytosis of both CAPS Is Partly Membrane Associated
DCVs and SVs in endocrine and neural cells is shared, Subcellular fractionation studies were undertaken to
which includes the membrane-associated SNARE (syn- identify cellular fractions in which CAPS is localized in
aptosome-associated protein receptor) proteins VAMP an effort to clarify the mechanism underlying its function
(vesicle-associated membrane protein), syntaxin, and in exocytosis. Although CAPS was discovered as brain
SNAP-25 (synaptosome-associated protein [z25 kDa]) cytosolic protein that reconstitutes the Ca21-dependent
(Niemann et al., 1993; Sollner et al., 1993a; Martin, 1994). exocytosis of DCVs (Walent et al., 1992), a substantial por-
Differences in the physiological regulation of neural DCV tion of the protein was also found to be membrane asso-
and SV exocytosis suggest that the molecular mecha- ciated (Figure 1). Soluble CAPS was detected in brain
homogenates (Figure 1A, S2), but z37% of the proteinnisms may not be identical (see Discussion); however,
sedimented with particulate fractions (P2 and P3). Frac-the molecular basis for these apparent differences re-
tionation of the P2 pellet revealed an enrichment ofmains to be elucidated.
CAPS in synaptosomes (fraction B) relative to myelin
fractions (fraction A), mitochondria (fraction C), and mi-
crosomes (P3) (Figure1A). A portionof the CAPS(z38%)³To whom correspondence should be addressed.
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Figure 1. Membrane Association of CAPS in Brain Homogenates
(A) CAPS content in subcellular fractions. Fractionation of a rat brain homogenate was conducted as described by Whittaker (1969). Homoge-
nates were clarified at 1,000 3 g and centrifuged at 17,000 3 g. S2 is the supernatant; P2 is the corresponding pellet; P3 is the microsomal
pellet fraction derived from S2 by centrifugation at 100,000 3 g; and A, B, and C are myelin, synaptosomal, and mitochondrial fractions,
respectively, derived from P2. CAPS content was determined by Western blotting, and densitometer values in arbitrary units are shown
normalized to protein (left) or as total CAPS per fraction (right). The average of three separate determinations is shown.
(B) CAPS is a membrane-associated protein in synaptosomes. Synaptosomes were incubated in 1% Triton X-100 and centrifuged for analysis
of CAPS in the Triton-soluble (lane 1) and Triton-insoluble fraction (lane 2). Synaptosomes were subjected to hypotonic lysis and centrifuged
for analysis of the pellet fraction (lane 3). Intact synaptosomes were analyzed in lane 4. VAMP was used as a membrane marker.
sedimented with membranes following hypotonic rup- membrane fragments that were purified by differential
centrifugation and affinity isolation on immobilized con-ture of synaptosomes (Figure 1B). In contrast, Triton
X-100 completely solubilized synaptosomal CAPS (Fig- canavalin A. CAPS was found to coisolate with the affin-
ity-purified plasma membrane fragments (Figure 3, laneure 1B). The results indicate that much of the total CAPS
in synaptosomes is membrane associated, while virtu- 3). As anticipated, purified plasma membranes (Figure 3,
lane 3) were enriched for the plasma membrane markerally none is stably associated with detergent-insoluble
cytoskeletal elements. The sequence of CAPS is novel neuronal cell adhesion molecule (NCAM) and de-enriched
for mitochondrial marker protein prohibitin. Plasma mem-(Ann et al., 1997) but exhibits some similarity to actin-
binding proteins (Wassenberg et al., submitted). The branes were not contaminated by DCV membranes as
indicated by the absence of the DCV protein SgII inlack of association of CAPS with Triton-insoluble F ac-
tin±containing structures is consistent with recent stud- either the crude or purified plasma membrane fractions
ies demonstrating the absence of a requirement for F (data not shown). Immunofluorescence studies in PC12
actin in CAPS function (Wassenberg et al., submitted). cells recently detected a plasma membrane localization
To determine whether CAPS was associated with for CAPS consistent with the biochemical localization
other proteins in the membrane, detergent-soluble pro- reported here for synaptosomes.
tein complexes were analyzed on Triton X-100±contain- An affinity-purified polyclonal antibody generated to
ing sucrose gradients (Figure 2A). CAPS was distributed a recombinant CAPS protein was employed for immuno-
in a single peak in the gradient that overlapped but was gold localization studies. In lysed synaptosomes, gold
not coincident with the previously characterized 7 S particles were found to be distributed on the plasma
SNARE complex that contains syntaxin, VAMP, and membrane but not on the internal membranes consisting
SNAP-25 (Sollner et al., 1993b). Immunoprecipitation of largely of SVs (Figures 4A±4C). In a partially purified
gradient fractions with VAMP or CAPS antibodies failed plasma membrane fraction, gold particles were concen-
to detect an association of CAPS with VAMP (data not trated on the surface of membranes that also contained
shown). CAPS sedimentation was indistinguishable in the neuronal plasma membrane marker syntaxin (Fig-
the absence or presence of Ca21 (Figure 2A), exhibiting ures 4D±4F), confirming a plasma membrane localiza-
in both cases a sedimentation coefficient of z10 S that tion for CAPS.
likely corresponds to the soluble CAPS dimer of 145 To assess whether CAPS was also associated with
kDa subunits (Walent et al., 1992). Similar sedimentation DCV and/or SV membranes, enriched pools of large
characteristics were exhibited by a recombinant CAPS DCVs or small SVs were prepared (see Experimental
protein analyzed either alone or in the presence of the Procedures). As determined by Western blotting, CAPS
Triton extract (Figure 2B). The results indicate that CAPS was greatly enriched in the DCV pool relative to the SV
is not membrane bound via stable associations with pool (Figure 5A) despite the low purity of DCVs in this
other membrane proteins. pool. Velocity sedimentation on sucrose gradients was
conducted to further analyze DCVs and SVs in these
pools using VAMP immunoreactivity to monitor bothCAPS Is Selective in Its Membrane Association
Further fractionation was undertaken to identify specific classes of vesicles. This analysis showed that CAPS
cosedimented with large DCVs but not with small SVsmembranes with which CAPS is associated. Synapto-
somes were thoroughly homogenized to produce plasma (Figures 5B and 5C). The low levels of CAPS in the SV
CAPS Is a Component of Dense-Core Vesicles
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Figure 3. CAPS Is Localized to Plasma Membranes
A crude plasma membrane fraction was obtained by homogeniza-
tion of synaptosomes followed by differential centrifugation. Follow-
ing incubation with concanavalin A-agarose and centrifugation, the
conconavalin A-agarose pellet (lane 3) was analyzed and compared
to an equal portion of the input material (lane 2) by Western blotting.
Synaptosomes were also analyzed for comparison (lane 1). Differen-
tial centrifugation and concanavalin A-agarose retention resulted in
the isolation of a plasma membrane marker NCAM, the loss of a
mitochondrial marker (prohibitin), and the coisolation of CAPS. The
DCV marker SgII was present in synaptosomes but absent in the
input membrane fraction and the conconavalin A-agarose pellet
(data not shown).
DCVs (Figure 5D, lane 3), but alkaline bicarbonate was
Figure 2. Sucrose Gradient Analysis of Detergent-Solubilized Syn- effective (Figure 5E, lane 1). Alkalai-washed DCVs were
aptosomes capable of rebinding CAPS (Figure 5E, lane 2; see also
Synaptosomes were solubilized in 1% Triton X-100 and resolved on Figure 7). The results indicated that CAPS was accessi-
0.1±0.6 M linear sucrose gradients containing 0.1% Triton. Twenty
ble on the surface of DCVs with which it associates asfractions were collected.
a peripherally bound membrane protein.(A) Profiles of syntaxin (black squares) and CAPS in the absence
To further assess the apparent specific localization(white squares) or presence (gray squares) of 50 mM Ca21.
(B, top) Recombinant CAPS (bCAPS) was added to the detergent- of CAPS to DCV but not SV membranes, immunoisola-
soluble extract prior to centrifugation, and fractions were analyzed tion of vesicles from brain homogenateswas conducted.
for CAPS by Western blotting. Upper and lower bands correspond Aliquots of SVs and DCVs resolved by velocity sucrose
to recombinant and native CAPS, respectively.
gradients were subjected to immunoisolation with mono-(B, bottom) Syntaxin was determined by Western blotting. BSA (4.3
clonal antibodies directed against synaptotagmin (pres-S) and a2-macroglobulin (20 S) standards sedimented in fractions
ent on both SVs and DCVs), synaptophysin (preferen-4 and 20, respectively. The position of 7 S is indicated by an ar-
rowhead. tially on SVs), or normal mouse serum (Figure 6). CAPS
was recovered on synaptotagmin-containing vesicles
from the DCV fractions (lane 2) but not on synaptotag-
min-containing vesicles from the SV fractions (lane 5).pool sedimented farther into the gradient than did the
main peak of VAMP associated with SVs (Figure 5B, SVs were efficiently isolated with synaptophysin anti-
bodies but lacked CAPS (lane 6). In contrast, DCVs iso-arrowhead). The DCV pool contained large DCVs indi-
cated by the faster sedimenting peak of VAMP (Figure lated with synaptophysin antibodies contained CAPS
(lane 3). The results indicate that CAPS is localized pref-5C, arrowhead) as well as smaller vesicles indicated by
the slower sedimenting VAMP peak. CAPS in the DCV erentially to DCVs but not SVs. Calibrations conducted
with recombinant VAMP provided an estimate of onepool sedimented with the large DCVs (Figure 5C, arrow-
head). The distinct sedimentation characteristics of the molecule of CAPS for every three molecules of VAMP
on immunoisolated DCVs. In agreement with the immu-large DCVs and small SVs in these gradients was con-
firmed by immunoblotting for synaptophysin (enriched noisolation studies, immunogold localization studies
with CAPS antibody revealed gold particles associatedin small SVs), for SgII (specific to DCVs), and for synapto-
tagmin (present on both vesicle classes) (data not shown). with DCVs in the crude DCV fraction but not with other
membranes in this preparation (Figures 4G±4I), althoughCosedimentation of CAPS with DCVs was also observed
on equilibrium gradients (data not shown). Hence, CAPS the apparent density of CAPS on the DCV membrane
may be lower than that observed on the plasma mem-associates with membranes that have the velocity sedi-
mentation and density characteristics of large DCVs. brane.
To exclude the possibility that CAPS, abundant in
cytosol, was entrapped in vesicles formed during ho- CAPS Binds Directly to DCV Membranes
with High Affinitymogenization, the accessibility of CAPS to proteases
was determined. CAPS was degraded by proteases un- The association of CAPS with DCV membranes was
further investigated with chromaffin granules, which areder conditions in which vesicular VAMP was cleaved
but a DCV content marker (SgII) was protected (Figure readily purified from adrenal medullary tissue. In con-
trast to DCVs from brain, little CAPS was present on5D, lanes 4 and 5). High salt failed to extract CAPS from
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Figure 4. CAPS Associates Selectively with Plasma Membranes and DCVs
Immunogold localizations with affinity-purified CAPS antibody were conducted as described in the Experimental Procedures.
(A±C) The localization of CAPS in lysed synaptosomes was restricted to the plasma membrane (10 nm gold, arrows). The gold-conjugated
secondary used was goat anti-rabbit IgG.
(D±F) CAPS (10 nm gold, arrows) colocalized in partially purified plasma membranes with syntaxin (5 nm gold, arrowheads). The gold-
conjugated secondary used for CAPS antibody was protein A.
(G±I) CAPS localized to the surface of DCVs but not other membranes in a partially purified DCV preparation. The gold-conjugated secondary
used for CAPS antibody was protein A. Dilutions of gold-conjugated secondary reagents were used that produced no immunogold staining
in the absence of primary antibodies. Scale bar in all panels, 50 nm.
purified chromaffin granules.However, incubation of the in synaptosomes. Synaptosomes were ruptured by hy-
potonic lysis and synaptosomal DCVs were loaded withchromaffin granules with rat brain cytosol or purified
[3H]norepinephrine in preincubations with MgATP. TheCAPS resulted in the binding of CAPS to these DCVs,
uptake of [3H]norepinephrine by lysed synaptosomeswhich was detected by sedimentation of the granules
occurred by a reserpine-sensitive process. Preloadedthrough a sucrose cushion based on their characteristic
synaptosomes were washed and incubated to detectsize and density (Figure 7). CAPS binding to chromaffin
the release of [3H]norepinephrine. Approximately 20%DCVs was saturable and exhibited high apparent affinity
of the loaded [3H]norepinephrine was released in a(KD ≈ 3 3 1027 M). CAPS binding was neither ATP nor
Ca21-independent manner during a 5 min incubation atCa21 dependent, nor did preincubation of the mem-
308C, presumably reflecting leakage from the vesiclesbranes with a polyphosphoinositide-specific phospholi-
(Figure 8). However, the inclusion of 35 mM Ca21 resultedpase C alter the binding (data not shown). CAPS bound
in an additional 20% release during the incubation. Fur-equally well to granules that had been treated with tryp-
ther studies showed that the Ca21-dependent activationsin under conditions where VAMP was digested (Figure
of norepinephrine release was half maximal at z25 mM7, inset). This result indicates that high affinity DCV bind-
and maximal by 100 mM Ca21 (data not shown), indicat-ing by CAPS is not mediated by trypsin-sensitive pro-
ing that a high affinity Ca21-triggered exocytotic processteins and is likely due to direct interactions with mem-
characteristic of DCVs was functional in this prepara-
brane phospholipids.
tion. That the Ca21-dependent, but not the Ca21-inde-
pendent, portion of norepinephrine release was indeed
CAPS Functions As a Membrane-Bound Protein by exocytosis rather than leakage was indicated by the
To determine whether CAPS is required for neurotrans- complete inhibition of this component by incubation
mitter secretion in the central nervous system, an assay with botulinum neurotoxin type E, a proteasethat specif-
ically hydrolyzes SNAP-25 (Figure 8).was developed todetect Ca21-activated DCVexocytosis
CAPS Is a Component of Dense-Core Vesicles
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Figure 5. CAPS Is Associated with DCVs as a Peripherally Bound Membrane Protein
(A) Pools of DCVs (lane 1) and SVs (lane 2) prepared as described in Experimental Procedures
were analyzed for CAPS and VAMP by Western blotting (50 mg total protein per lane).
(B and C) Velocity gradient analysis of SV (B) and DCV (C) pools. Vesicle pools were sedimented
on 0.3±1.2 M linear sucrose gradients and analyzed by Western blotting for CAPS and VAMP.
Arrowheads indicate the SV peak in (B) and the DCV peak in (C), respectively.
(D) Equal amounts of the DCV pool (lane 1) were incubated in buffers adjusted to 0.2 M KCl
(lane 2), 0.8 M KCl (lane 3) or treated with trypsin (lane 4) or subtilisin (lane 5). Membranes
were recovered by centrifugation at 100,000 3 g through a 0.3 M sucrose pad and analyzed
by Western blotting for CAPS, SgII, and VAMP.
(E) Membranes in the DCV pool (lane 3) were washed in sodium bicarbonate (pH 8.5) (lane 1)
and recovered for Western blotting or were neutralized and incubated with rat brain cytosol (lane 2, 1CAPS) for analysis of CAPS rebinding.
Lysed synaptosomes retained membrane-bound CAPS A high affinity and saturable interaction of CAPS with
chromaffin DCV membranes appeared to be mediated(data not shown), and the Ca21-dependent component
by a trypsin-insensitive component. Hence, CAPS ap-of norepinephrine release was found to be completely
pears to bea membrane-binding protein that specificallyblocked by preincubation with an IgG fraction of CAPS
localizes to membranes that are involved in DCV exo-immune serum (Figure 8). In contrast, IgGs from preim-
cytosis.mune serum had virtually no effect (Figure 8). These
The results of in vitro binding studies of CAPS toresults further extend to brain monoaminergic DCVs the
liposomes are consistent with a suggested direct asso-role for CAPS in exocytosis initially demonstrated for
ciation of CAPS with membranes (Loyet et al., 1998).DCVs in GH3 pituitary and PC12 adrenal endocrine cells.
CAPS exhibits an interaction with liposomes that containMoreover, the results demonstrate that the membrane-
the acidic phospholipids phosphatidylserine and phos-bound fraction of CAPS in synaptosomes is functional
phatidylinositol found abundantly in the cytoplasmicfor the Ca21-dependent exocytosis of DCVs.
leaflet of cellular membranes. CAPS binding was found
to be markedly enhanced by inclusion of PtdIns(4,5)P2Discussion
but not equally or more acidic phospholipids in the lipo-
somes (Loyet et al., 1998). In the present studies, CAPSCAPS was originally isolated as a cytosolic factor that
binding to chromaffin DCVs did not require ATP, norreconstitutes Ca21-activated secretion via DCV exo-
was it affected by treatment with phospholipase C undercytosis in permeable neuroendocrine cells (Walent et
conditions that hydrolyze PtdIns(4,5)P2. This suggestsal., 1992). Sequence analysis indicated that CAPS is
that CAPS membrane associations may be mediated
a novel protein but exhibits some similarity to several
generally by interactions with acidic phospholipids in
cytoskeletal proteins (Ann et al., 1997; Wassenberg et the cytoplasmic leaflet rather than specifically with
al., submitted). Although in vitro cosedimentation assays PtdIns(4,5)P2. CAPS has also been found to undergo a
demonstrated that CAPS is a high affinity F actin± conformational change when bound to PtdIns(4,5)P2 but
binding protein, actin cytoskeleton disassembly had no not other phospholipids (Loyet et al., 1998). It is possible
effect on the activity of CAPS in regulated exocytosis, that PtdIns(4,5)P2 formation on DCVs catalyzed by prim-
indicating that F actin binding is not essential (Wassen- ing factors required for secretion (Hay and Martin, 1992;
berg et al., submitted). In the present studies, we found Hay et al., 1995) could stabilize membrane binding by
little CAPS associated with a detergent-insoluble cy- CAPS or allosterically regulate CAPS±membrane inter-
toskeletal fraction in brain tissue, confirming that CAPS actions. Additional studies will be required to assess
does not function as a cytoskeletal component. In con- this possibility and to determine why CAPS stably asso-
trast, a substantial portion of CAPS was membrane as- ciates with the plasma membrane and DCV membranes
sociated in synaptosomes and localized to specific but not with other neuronal membranes, including SVs.
membranes, which included plasma membranes and Estimates of the high CAPS concentration (z0.1 mM)
DCV membranes but not SV membranes. CAPS was present in cytosol (Walent et al., 1992), which is a highly
associated with DCVs as a peripherally bound protein diluted version of cytoplasm, and of the binding affinity
to DCV membranes (KD ≈ 0.3 mM; Figure 7) indicate thatthat was extractable in high pH but not high salt buffers.
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Figure 6. CAPS Coimmunoisolates with DCVs but Not SVs
Rat brain homogenates were layered onto 0.3±1.2 M linear sucrose
gradients for velocity centrifugation and 20 fractions were collected
and analyzed by Western blotting for CAPS, SgII, synaptophysin,
and VAMP. Peak fractions containing large DCVs (lane 7) and SVs
Figure 8. Ca21-Activated Release of [3H]Norepinephrine from Lysed(lane 8) were used for immunoisolations. DCVs (lanes 1±3) or SVs
Synaptosomes Is CAPS Dependent(lanes 4±6) were subjected to immunoprecipitation with normal
mouse serum (lanes 1 and 4), synaptotagmin monoclonal antibody Synaptosomes were hypotonically lysed and aliquots were incu-
(lanes 2 and 5), or synaptophysin monoclonal antibody (lanes 3 and bated on ice for 15 min with 0.5 mM botulinum neurotoxin E (BoNT
6). Immunoprecipitated (IP) vesicles retained on protein G-Sepha- E), 1 mg/ml CAPS immune immunoglobulins (aCAPS IgG), or 1 mg/
rose beads were solublized in sample buffer and analyzed by West- ml immunoglobulins purified from preimmune serum (PIaCAPS IgG)
ern blotting for NCAM, CAPS, synaptotagmin, synaptophysin, and as indicated. These were further incubated with [3H]norepinephrine
VAMP. in the presence of MgATP for 15 min at 308C and washed. Resus-
pended synaptosomes were further incubated for 5 min on ice or
at 308C with or without 35 mM Ca21 as indicated. [3H]norepinephrine
in supernatants was determined following centrifugation. Error barsCAPS membrane-binding sites would be fully occupied
indicate SEM for quadruplicate determinations.
in neural and endocrine cells.
The present studies indicate that not only does CAPS
associate with membranes but likely functions as a membrane-associated factor. The requirement for en-
dogenous membrane-bound CAPS for Ca21-activated
norepinephrine secretion in lysed synaptosomes was
indicated by the inhibition of secretion by CAPS antibod-
ies. The high Ca21 sensitivity of norepinephrine release
from lysed synaptosomes (EC50 ≈ 25 mM) observed in
our experiments is characteristic of exocytotic fusion
for DCVs (Verhage et al., 1991; Thomas et al., 1993;
Chow et al., 1994), whereas SV exocytosis is triggered
at substantially higher Ca21 concentrations (Verhage et
al., 1991; Heidelberger et al., 1994). It is likely that the
CAPS requirement for Ca21-activated norepinephrine
release from lysed synaptosomes is the functional coun-
terpart of the physical localization of CAPS on large
DCVs and the plasma membrane.
There are apparent differences in the physiological
regulation of neurotransmitter secretion involving SV or
DCV exocytosis. SVs docked at active zones near the
presynaptic membrane undergo extremely rapid (von
Gersdorff and Matthews, 1994; Sabatini and Regehr,
1996) fusion triggered by binding of Ca21 to a low affinity
sensor (Geppert et al., 1994; Heidelberger et al., 1994).
In contrast, DCVs are typically excluded from active
zones (Thureson-Klein, 1983; Bruns and Jahn, 1995), un-
Figure 7. CAPS Binding to Chromaffin DCVs Is Saturable dergo exocytosis at lower Ca21 concentrations (Thomas
Purified chromaffin granules were incubated with CAPS at the indi- et al., 1993; Chow et al., 1994), exhibit longer latencies
cated concentrations for 15 min at 308C and recovered by centrifu- between stimulus and fusion (Chow et al., 1992; Bruns
gation through 1.5 M sucrose for Western blotting analysis of CAPS.
and Jahn, 1995), and show prolonged secretory re-(Inset) CAPS binding to trypsin-treated (lane 2) granules was com-
sponses (Thomas et al., 1993). The physiological differ-pared to that of untreated granules (lane 1). Western blotting of
VAMP was used to assess efficacy of trypsin digestion. ences in the regulation of DCV and SV exocytosis in
CAPS Is a Component of Dense-Core Vesicles
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and centrifuged at 17,000 3 g for 55 min, resulting in the S2 superna-nerve cells suggest that the molecular mechanisms in
tant and the P2 pellet. S2 was centrifuged at 100,000 3 g for 1 hrthese pathways for regulated secretion are not identical.
to generate the P3 pellet. P2 was resuspended in 0.32 M sucroseIn subcellular fractionation and electron microscopic
and layered onto a 1.2 M, 0.8 M block sucrose gradient. Following
studies, CAPS was found to localize to DCVs. Studies centrifugation at 53,000 3 g for 2 hr, fractions A (0.32/0.8 M bound-
of Ca21-activated norepinephrine secretion in lysed syn- ary), B (0.8/1.2 M boundary), and C (pellet below 1.2 M) were col-
lected and centrifuged at 100,000 3 g for 1 hr to isolate membranes.aptosomes demonstrated that CAPS is indeed essential
For detergent extraction, synaptosomes were incubated with 1%for regulated DCV exocytosis in nerve cells, as is the
Triton X-100 for 20 min on ice and centrifuged at 14,000 3 g for 15case for endocrine cells (Walent et al., 1992; Ann et al.,
min to obtain the supernatant and pellet fractions for SDS-PAGE1997). In contrast, subcellular fractionation and electron
analysis. For hypotonic lysis, synaptosomes were added to 9 vol
microscopic studies failed to detect CAPS on SVs. cold water, homogenized in a Dounce homogenizer, incubated 20
These observations suggest the possibility that CAPS min on ice, and centrifuged for 20 min at 100,000 3 g to isolate the
pellet fraction for SDS-PAGE analysis.could function selectively in the DCV but not the SV
For analysis of detergent-solubilized CAPS, synaptosomes wereexocytotic pathway. Due to excessive leakage of gluta-
extracted in 100 mM KCl, 20 mM HEPES (pH 7.3), 1 mM BAPTA,mate from SVs in the lysed synaptosome preparation,
and 2% Triton X-100, with or without 1 mM CaCl2, for 30 min onit was not possible in the present studies to assess
ice. Insoluble material was removed by centrifugation for 15 min at
directly a role for CAPS in SV exocytosis. However, Tan- 16,000 3 g,and the resulting supernatants were layered onto0.1±0.6
don et al. (1998 [this issue of Neuron]) have recently M linear sucrose gradients (containing 0.1% Triton X-100, 1 mM
BAPTA, and 20 mM HEPES, with or without 1 mM CaCl2). Followingconducted functional studies in streptolysin O±per-
overnight centrifugation at 180,000 3 g in a SW41 rotor, fractionsmeabilized (SLO-permeabilized) synaptosomes in which
were collected from the bottom of each tube with the aid of aregulated DCV and SV exocytosis were studied in paral-
Gilson peristaltic pump. Where indicated, baculovirus-expressedlel. Their results indicate a requirement for CAPS in regu-
CAPS (Ann et al., 1997) was added to the Triton X-100 soluble
lated DCV exocytosis, whereas no comparable require- fraction prior to centrifugation. BSA (bovine serum albumin) (Sigma
ment was detected for CAPS in the SV-mediated release Chemical) and a2-macroglobulin (Calbiochem-Novabiochem) were
utilized as sedimentation standards.of glutamate. Taken together, the localization results
For plasma membrane isolations, synaptosomes were hypotoni-presented here and the functional studies of Tandon et
cally lysed as above, extensively homogenized by Dounce, andal. (1998) provide strong support for the conclusion that
centrifuged twice at 1,000 3 g for 10 min. Supernatants were centri-CAPS is a component specific for the DCV exocytotic
fuged at 15,000 3 g for 10 min, and the pellet was resuspended in
apparatus. phosphate buffered saline (PBS) supplemented with MnCl2 and
A universal fusion mechanism that utilizes small SVs CaCl2. Following clarification by centrifugation at 1,000 3 g for 10
min, supernatants were incubated with rocking for .4 hr at 48C withand constitutive vesicles of 40±50 nm in diameter may
concanavalin A-agarose (Sigma Chemical), after which the agaroserequire accessory proteins to accommodate the fusion
beads were collected by centrifugation at 1,000 3 g for 10 min.of larger diameter DCVs. Accessory proteins may be
Membranes in the supernatant were collected by centrifugation atrequired for bending the membrane of larger diameter
100,000 3 g for 1 hr and dissolved in SDS sample buffer. Agarose
vesicles or for promoting interactions between a vesicle beads were washed by centrifugation in PBS and boiled in SDS
membrane of lower curvature and the plasma mem- sample buffer. Mitochondrial contamination was assessed in West-
brane. As a phospholipid-binding protein that acts at a ern blotting with a monoclonal antibody to prohibitin (NeoMarkers,
Freemont, CA).late stage in exocytosis, CAPS may serve these roles. As
Large DCV and SV fractions from rat brain homogenates werea component specific for the DCV exocytotic apparatus,
prepared as previously described using a 10%±30% isoosmoticCAPS could confer some of the physiological regulatory
Nycodenz gradient and Sephacryl S-1000 chromatography (Floor
features that are distinct to neuropeptide and biogenic et al., 1988). Large DCVs (70±100 nm) containing neuropeptides and
amine secretion. Because CAPS is a Ca21-binding pro- exhibiting catecholamine transport activity are enriched in fractions
tein (Ann et al., 1997), it could contribute to the differ- that elute between the void volume and the SV peak on Sephacryl
S-1000 (Floor et al., 1982). The SV pool contains smaller vesiclesences in Ca21 sensitivity for regulated SV and DCV exo-
(z40 nm), some of which are also monaminergic (Floor et al., 1995).cytosis.
CAPS corresponds to the vertebrate homolog of the
Vesicle ImmunoisolationC. elegans UNC-31 protein (Ann et al., 1997), whose loss
For analysis of vesicles from total brain homogenates, rat brainsof function results in a unique phenotype with distinct
were homogenized in 0.16 M KCl, 0.01 M HEPES (pH 7.3), and 0.001and widespread nervous system dysfunction that may
M EGTA and centrifuged at 20,000 3 g for 10 min. Supernatants
involve specific subsets of neurotransmitters. Disregu- were layered onto 0.3±1.2 M linear sucrose gradients (containing
lated serotonin secretion via DCVs, detected as neu- 0.01 M HEPES) and centrifuged for 90 min (velocity centrifugation)
ronal transmitter accumulation, has been characterized or overnight (equilibrium centrifugation) at 100,000 3 g in an SW41
rotor. Fractions that were enriched for DCVs or SVs were dilutedin unc-31 mutants (Desai et al., 1988), but the secretion
1:5 into KGlu buffer (20 mM HEPES [pH 7.2], 120 mM potassiumof other transmitters has not yet been examined. C.
glutamate, 20 mM potassium acetate, 2 mM EGTA, and 0.1% BSA)elegans unc-31 mutants could provide an important sys-
and rocked with normal mouse serum, monoclonal antibody 3G12
tem for further study of the role of the CAPS/UNC-31 (synaptophysin), or antibody 48 (synaptotagmin) overnight at 48C.
protein in neurosecretion and its selective role in DCV Protein G-agarose (Sigma Chemical Company) was subsequently
exocytosis. added, and rocking continued for at least 2 more hr at 48C. Agarose
beads were washed thoroughly in KGlu by centrifugation and boiled
in SDS sample buffer for gel analysis. Western blotting was con-Experimental Procedures
ducted with monoclonal antibodies to NCAM and syntaxin (Sigma
Chemical), to synaptophysin (Boehringer-Mannheim), and to VAMPSubcellular Fractionation and Vesicle Purification
(monoclonal Cl 69.1 generously provided by R. Jahn; see Walch-Fractionation of brain tissue was performed as per Whittaker (1969).
Solimena et al., 1995) and with polyclonal antibodies to synaptotag-Briefly, rat brains were homogenized in 0.32 M sucrose and centri-
fuged at 1,000 3 g for 10 min. The supernatant (S1) was collected min (generously provided by M. Takahashi) and secretogranin II
Neuron
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(generously provided by W. Huttner). The CAPS polyclonal antibod- (free ionic). Following incubation at 308C for 5 min, [3H]norepi-
nephrine release was determined following centrifugation aties used for Western blotting throughout this study were either gen-
erated against the native purified protein or to a conjugated peptide 14,000 3 g for 15 min by liquidscintillation counting of supernatants.
representing residues 574±589.
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